Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature
We report a patient with multiple endocrine neoplasia type 1 with pancreatic polypeptide (PP) secreting subcentimeter pancreatic neuroendocrine tumors (pNETs) treated with octreotide and review the current literature that pertains to the management of these patients. Clinical data, laboratory result...
Saved in:
Main Authors: | Matthew H. Kemm, Cory D. Manly, Thanh D. Hoang, Vinh Q. Mai, Mohamed K. M. Shakir |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Gastrointestinal Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/9462942 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor
by: Kocfa Chung-Delgado, et al.
Published: (2013-01-01) -
The natural course of cystic pancreatic neuroendocrine tumours in MEN1
by: Eline N M van Vliembergen, et al.
Published: (2025-02-01) -
Outcomes after Surgery for Malignant Pancreatic Neuroendocrine Tumors
by: Omar Hama Ghalib Azeez Hawramy, et al.
Published: (2019-08-01) -
Pancreatic Neuroendocrine Tumor in the Setting of Dorsal Agenesis of the Pancreas
by: Samih Nassif, et al.
Published: (2016-01-01) -
PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis
by: Wen Bao, et al.
Published: (2021-01-01)